What Express Scripts Holding Co.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Granger Elder | Director | Dec 20 | Disposition to Issuer · D | −6,523 | — | — | 0 |
| Neville Everett | Exe VP, Strat, Sup Chn & Spclt | Dec 20 | Disposition to Issuer · D | −31,049 | — | — | 0 |
| Miller Steven B | Sr. VP & Chief Med. Officer | Dec 20 | Disposition to Issuer · D | −43,800 | — | — | 0 |
| Myers Woodrow A Jr | Director | Dec 20 | Disposition to Issuer · D | −14,318 | — | — | 0 |
| Wentworth Timothy C | President & CEO | Dec 20 | Disposition to Issuer · D | −157,261 | — | — | 0 |
| Wentworth Timothy C | President & CEO | Dec 20 | Disposition to Issuer · D | −135,255 | — | — | 0 |
| Mazzarella Kathleen M | Director | Dec 20 | Disposition to Issuer · D | −2,466 | — | — | 0 |
| Akins Martin P. | Sr. VP & General Counsel | Dec 20 | Disposition to Issuer · D | −46,219 | — | — | 0 |
| DeLaney William J Iii | Director | Dec 20 | Disposition to Issuer · D | −14,989 | — | — | 0 |
| Mergenthaler Frank | Director | Dec 20 | Disposition to Issuer · D | −38,005 | — | — | 0 |
| Anderson Phyllis S. | Sr. VP & Ch. Marketing Officer | Dec 20 | Disposition to Issuer · D | −17,317 | — | — | 0 |
| Guerrier Ron | Sr. VP and Chief Info. Officer | Dec 20 | Disposition to Issuer · D | −10,199 | — | — | 0 |
| Lahowchic Nicholas | Director | Dec 20 | Disposition to Issuer · D | −36,647 | — | — | 0 |
| Arlotta John | CEO, eviCore healthcare | Dec 20 | Disposition to Issuer · D | −6,688 | — | — | 0 |
| Phillips Bradley E | VP, Controller and CAO | Dec 20 | Disposition to Issuer · D | −14,881 | — | — | 0 |
| Roper William L | Director | Dec 20 | Disposition to Issuer · D | −52 | — | — | 0 |
| Roper William L | Director | Dec 20 | Disposition to Issuer · D | −18,918 | — | — | 0 |
| Havel James M | Executive VP and CFO | Dec 20 | Disposition to Issuer · D | −57,833 | — | — | 0 |
| Seiz Brian | Sr. VP, Specialty | Dec 20 | Disposition to Issuer · D | −32,118 | — | — | 0 |
| Breen Maura C | Director | Dec 20 | Disposition to Issuer · D | −27,305 | — | — | 0 |
Loading...
